Anil Vedula MD Financial Disclosures: None Richard M. Awdeh MD

Slides:

Advertisements

Similar presentations

Venting Incisions in DSAEK Patients: Is It an Absolute Necessity?

Advertisements

Use of a Novel Y- Suture Technique to Reduce Detachments in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Habeeb Ahmad, MD Martin Heur,

The authors have no financial interests to disclose

Retrospective comparison of staged versus combined cataract surgery and Descemet’s-stripping endothelial keratoplasty (DSEK) in patients with Fuchs’ Dystrophy.

Early Outcomes of Descemet’s Stripping Automated Endothelial Keratoplasty in Pseudophakic Eyes with Anterior Chamber Intraocular Lenses Preeya K. Gupta.

Roy E Lehman MD*, Samuel F Fulcher MD**

Relationship Between Donor Graft Cell Count and Visual Outcome in DSAEK Patients Authors Silvin Bakalian MD PhD, Johanna Choremis MD FRCSC, Michele Mabon.

V. S. Liarakos, K. van Dijk, L. Ham, L. Baydoun and G.R.J. Melles Anterior Chamber vs Posterior Chamber IOL in DMEK for Pseudophakic Bullous Keratopathy.

Department of Ophthalmology, University Hospital Ayr, Scotland

Jeffrey J. Ing, MD, FACS, (Delta Eye Medical Group, Loma Linda University School of Medicine, Department of Ophthalmology) Thanh T. Nguyen, OD (Delta Eye.

DSAEK in Eyes With Severe Pre-operative Visual Acuity Loss. 1. Sightline Ophthalmic Associates, Pittsburgh, PA 2. Devers Eye Institute, Portland, OR 3.

Dislocation of the DSEK Donor Graft into the Posterior Segment An Intraoperative Complication in DSEK Surgery Mark M Fernandez MD, Mark S Gorovoy MD, George.

Bryan Y Kim 1, Shintaro Kanayama MD PhD 1, Tueng T Shen MD PhD 1, Thomas E Gillette MD 2 1 University of Washington Department of Ophthalmology, 2 Eye.

Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore

Evaluation of Corneal Parameters and Spherical Aberration After DSAEK Measured with Pentacam System Orkun Muftuoglu, Pawan Prasher, R. Wayne Bowman, Steven.

Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments.

Bowman’s layer Descemet’s membrane. Pathologic Diagnosis Diagnosis – Pseudophakic bullous keratopathy with Chronic bullous keratopathy Degenerative pannus.

Case Report of Severe Haze After DSAEK

Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.

Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting.

Tissue Complications During Endothelial Keratoplasty David B. Glasser, M.D. Columbia, MD The author has no financial interest in the subject matter of.

Natalie Stanciu, MD Richard M. Awdeh, MD Takeshi Ide, MD Sonia Yoo, MD Bascom Palmer Eye Institute ASCRS 2009: San Francisco.

AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.

Deep anterior lamellar keratoplasty in children World Cornea Congress April 2010 Boston, MA Asim Ali, MD, FRCSC University of Toronto Hospital for Sick.

1 Clinical Outcomes of DSEK Surgery Combined With Other Intraocular Procedures Neil Mahesh Vyas, MD Fei Yu, PhD Anthony J. Aldave, MD Sophie Deng, MD,

Epithelial Ingrowth Following Endothelial Keratoplasty Ritika Dalal, DNB Robert S. Feder, MD, Irving Raber, MD, Steven P. Dunn, MD, Robert Weisenthal,

Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Thickness and Asymmetry After DSAEK Dickman MM, Cheng YYY, Berendschot TTJM, van.

E-Poster Price Vision Group & Cornea Research Foundation of America Descemet - Stripping Endothelial Keratoplasty :Survival Outcomes in Eyes with Pre-

Efficacy of Bromfenac 0.09% in Prevention and Treatment of Pseudophakic CME When Used Preoperatively and Postoperatively by Melissa M. Cable, MD, FAAO,

Descemet-Stripping Automated Endothelial Keratoplasty Grafts Prepared from Endothelial Side Using a 500 kHz Femtosecond Laser: Six-Month Outcomes Jesper.

Successful Use of Corneal Tissue from LASIK Donors in Descemet-Stripping Automated Endothelial Keratoplasty: A Case Series Mark D. Mifflin, MD Majid Moshirfar,

Urrets-Zavalia Syndrome After Lamellar Corneal Transplant: Two Case Reports Timothy Y. Chou, MD, Sujata P. Prabhu, MD, Justin Dexter, MD Department of.

J. Brian Foster, MD No Financial Disclosures

Daniel D. Hayes, MD1; Carolyn Y. Shih, MD1; David C

Risk Factors and Outcomes of Donor Lenticule Dislocation Following DSEK Pravin K Vaddavalli MD, Suntia Chaurasia MD, Muralidhar Ramappa MD, Prashant Garg.

Jodhbir S Mehta, Donald Tan The Authors have a financial Interest in the Endoglide patent/royalty.

Etiological and decision making factors for repeat DSAEK or PK in cases of failed Descemet stripping automated endothelial keratoplasty First and Presenting.

World Cornea Congress VII - April 15-17, 2015 Electronic Poster

DSEK for the treatment of endothelial disease in India -Initial Experience in 80 eyes- Authors have no financial interest Dr Ashish Nagpal MD, FRCS Dr.

Post-Operative Management of Vitreous Adhesion after DSAEK with YAG Laser Vitreolysis Sherif Idris 1, Ahmed Al-Ghoul 2 MD FRCSC DipABO 1 University of.

Comparison of Endothelial Keratoplasty (EK) Visual Outcomes with OCT Derived Corneal Thickness Measurements Authors Abraham K. Sleem, MD Robert L. Schultze,

Hongseok Yang, MD Department of Ophthalmology, Ajou University School of medicine, Suwon, Korea The author has no financial interest.

First 25 Descemet Membrane Endothelial Keratoplasty (DMEK) Outcomes for an Experienced DSAEK Surgeon Authors: Victoria Epstein, MS.,DO, Josh Wallsh, MS-III,

Predicting Visual Acuity after Descemet’s Stripping Endothelial Keratoplasty using Corneal Topography, Pachymetry and Posterior Curvature Asymmetry Indices.

Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.

John P Berdahl M.D.* David R. Hardten M.D., F.A.C.S.* *No relevant financial disclosures.

0 Case Study Conflict of Interest Learning on the Job What your Patients Should Know.

Effect of Donor Processing and Storage Time and Preoperative Endothelial Cell Counts on DSAEK Detachment Rates Daniel Demsey BScE Stephanie Baxter MD,

Outcomes of Descemet Stripping Automated Endothelial Keratoplasty in patients with a Pre-Existing Anterior Chamber Intraocular Lens S. Elderkin1A, E. Tu1A,

Outcomes and Complications of DSEK in Eyes with Tube shunts or ACIOLs

World Cornea Congress VI April 7-9, 2010

Special considerations for DSEK in monocameral eyes

DSAEK using corneas with previous LASIK

Instituto Microcirugia Ocular

Endothelial keratoplasty in failed grafts

Kyoto Prefectural University of Medicine

Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.

Model of Hyperopic Shift After DSEK

New Concept of DSAEK Injecting System

H Nayak, A Patel, S Gudsoorkar, V Kumar University Hospital Wales

Hong A, Boehlke CS, Afshari NA, Kim T Duke University Medical Center

Comparison of Post-operative Pachymetry After Penetrating Keratoplasty Using Prednisolone Acetate 1% Versus Loteprednol Etabonate 0.5% E. Lillian Cheng,

Michael R. Banitt, MD, João Baptista Malta, MD, Roni M

Traumatic Wound Dehiscence After Corneal Keratoplasty

Glaucoma Progression after Descemet’s Stripping Endothelial Keratoplasty Neelofar Ghaznawi MD, Melissa B Daluvoy MD, Ajoy Virdi MD, Edwin S Chen, Kristin.

Role of HSV Infection in the Histopathology of Failed DSAEK

Anand K Shah MD1 Neda Shamie MD1 Paul Phillips MD1 Mark A Terry MD1,2*

The S. Fyodorov EYE MICROSURGERY STATE INSTITUTION, Moscow, Russia,

Presentation transcript:

Permanent Tattoo of a Descemet–Stripping Endothelial Keratoplasty Button Anil Vedula MD Financial Disclosures: None Richard M. Awdeh MD Financial Disclosures: Alcon (G), Allergan (S), Inspire (S), ISTA (C,S) David A. Goldman MD Financial Disclosures: Alcon (C), Allergan (C), ASCRS Foundation (G), Sirion (C), Inspire (C), ISTA (C) BASCOM PALMER EYE INSTITUTE

Purpose To describe a case of permanent tattooing of the corneal button after DSEK surgery.

Methods A 71-year-old male patient who presented with pseudophakic bullous keratopathy secondary to cataract surgery and intraocular lens exchange, subsequently underwent DSEK surgery. During the surgery, an "S" was marked on the donor stromal side to assist with orientation during the procedure.

Results After 6 months, the donor graft was well attached, the cornea was clear, and the patient had a visual acuity of 20/50 (limited by epiretinal membrane). The ink marking, however, persisted as a permanent tattoo of the donor button.

The ‘S’ remains in the interface

Effect of Nontoxic Gentian Violet Marking Pen on DSAEK Donor Tissue Viability by Using Vital Dye Assay. Cornea. 2008 Jun;27(5):562-4. Qualitatively assessed the endothelial damage on DSAEK donor tissue resulting from a gentian violet marking pen. Demonstrated that marking the DSAEK donor stromal surface with a gentian violet marker damages the endothelium. Suggested that surgeons should limit the size of the mark or use a an insertion technique that avoids confusion about orientation of the donor cornea.

Conclusion Use of ink to assist with orientation of the donor button in DSEK surgery should be kept to a minimum and to the peripheral cornea only to minimize any negative visual consequences. Furthermore, while our graft remained clear 6 months postoperatively, the literature demonstrates endothelial toxicity from gentian violet, another reason to minimize use of ink during DSAEK surgery.